LCI News and Press, Lannett Co Inc From 07/23/20

PHILADELPHIA , July 23, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has launched Mexiletine Hydrochloride Capsules 150 mg, 200 mg and 250 mg, a partnered product. Mexiletine Hydrochloride Capsules is the AB-rated generic equivalent to Mexitil ®...

Shares of Lannett Company (NYSE: LCI) were jumping 12.1% higher as of 11:35 a.m. EDT on Thursday. The nice gain came after the drugmaker announced a deal to distribute Cediprof's levothyroxine sodium tablets. Lannett stated that it plans to start distributing Cediprof's generic drug in the...

AC Immune (NASDAQ: ACIU ) +76%  on advancement of Alzheimer's vaccine study. More news on: AC Immune SA, Future FinTech Group Inc., Boxlight Corporation, Stocks on the move, , Read more ...

Lannett Company (NYSE: LCI ) inks an interim agreement with Neolpharma Pharmaceutical Group unit Cediprof for the exclusive supply and distribution of the latter's Levothyroxine Sodium Tablets USP. The contract runs until July 31, 2022, when the previously announced 10-year exclusive con...

PHILADELPHIA and CAGUAS, Puerto Rico , July 16, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) and Cediprof, Inc., a part of the Neolpharma Pharmaceutical Group family of companies, today said that the companies have entered into an interim exclusive supply and distribution...

Lannett ( LCI -9.1% ) said it will cut 80 positions, ~8.5% of its total workforce, over concerns that it may face pricing pressure in fiscal 2021 on certain key products, including generic Fluphenazine product. More news on: Lannett Company, Inc., Amneal Pharmaceuticals, Inc....

PHILADELPHIA , July 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost savings plan. The initiatives include consolidating the research and development (R&D) function into a single location in Philadelphia and lowering operating ...

PHILADELPHIA , June 11, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today said that representatives from the company spoke with and received guidance from the U.S. Food and Drug Administration (FDA) on the clinical advancement program of its biosimilar insulin glargine par...

A coalition of 51 attorneys general in the U.S. has filed an antitrust complaint  in federal court against 26 companies making generic dermatology drugs and 10 executives at these firms claiming wide-spread price-fixing, marketing allocating and bid-rigging related to over 80 different...

It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval, and price gougin...